A case-control study of infections caused by Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase-1: Predictors and outcomes. 2022

Eduardo Rodríguez-Noriega, and Elvira Garza-González, and Paola Bocanegra-Ibarias, and Beatriz Alejandra Paz-Velarde, and Sergio Esparza-Ahumada, and Esteban González-Díaz, and Héctor R Pérez-Gómez, and Rodrigo Escobedo-Sánchez, and Gerardo León-Garnica, and Rayo Morfín-Otero
Instituto de Patología Infecciosa y Experimental "Dr. Francisco Ruiz Sánchez", Centro Universitario de Ciencias de la Salud, Guadalajara, Mexico.

Infections caused by antimicrobial-resistant bacteria are a significant cause of death worldwide, and carbapenemase-producing bacteria are the principal agents. New Delhi metallo-beta-lactamase-1 producing Klebsiella pneumoniae (KP-NDM-1) is an extensively drug-resistant bacterium that has been previously reported in Mexico. Our aim was to conduct a case-control study to describe the risk factors associated with nosocomial infections caused by K. pneumoniae producing NDM-1 in a tertiary-care hospital in Mexico. A retrospective case-control study with patients hospitalized from January 2012 to February 2018 at the Hospital Civil de Guadalajara "Fray Antonio Alcalde" was designed. During this period, 139 patients with a culture that was positive for K. pneumoniae NDM-1 (cases) and 486 patients hospitalized in the same department and on the same date as the cases (controls) were included. Data were analyzed using SPSS v. 24, and logistic regression analysis was conducted to calculate the risk factors for KP-NDM-1 infection. One hundred and thirty-nine case patients with a KP-NDM-1 isolate and 486 control patients were analyzed. In the case group, acute renal failure was a significant comorbidity, hospitalization days were extended, and significantly more deaths occurred. In a multivariate analysis of risk factors, the independent variables included the previous use of antibiotics (odds ratio, OR = 12.252), the use of a urinary catheter (OR = 5.985), the use of a central venous catheter (OR = 5.518), the use of mechanical ventilation (OR = 3.459), and the length of intensive care unit (ICU) stay (OR = 2.334) as predictors of infection with NDM-1 K. pneumoniae. In this study, the previous use of antibiotics, the use of a urinary catheter, the use of a central venous catheter, the use of mechanical ventilation, and ICU stay were shown to be predictors of infection with NDM-1 K. pneumoniae and were independent risk factors for infection with NDM-1 K. pneumoniae.

UI MeSH Term Description Entries
D007710 Klebsiella Infections Infections with bacteria of the genus KLEBSIELLA. Infections, Klebsiella,Infection, Klebsiella,Klebsiella Infection
D007711 Klebsiella pneumoniae Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans. Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Eduardo Rodríguez-Noriega, and Elvira Garza-González, and Paola Bocanegra-Ibarias, and Beatriz Alejandra Paz-Velarde, and Sergio Esparza-Ahumada, and Esteban González-Díaz, and Héctor R Pérez-Gómez, and Rodrigo Escobedo-Sánchez, and Gerardo León-Garnica, and Rayo Morfín-Otero
February 2013, Microbial drug resistance (Larchmont, N.Y.),
Eduardo Rodríguez-Noriega, and Elvira Garza-González, and Paola Bocanegra-Ibarias, and Beatriz Alejandra Paz-Velarde, and Sergio Esparza-Ahumada, and Esteban González-Díaz, and Héctor R Pérez-Gómez, and Rodrigo Escobedo-Sánchez, and Gerardo León-Garnica, and Rayo Morfín-Otero
April 2016, Emerging infectious diseases,
Eduardo Rodríguez-Noriega, and Elvira Garza-González, and Paola Bocanegra-Ibarias, and Beatriz Alejandra Paz-Velarde, and Sergio Esparza-Ahumada, and Esteban González-Díaz, and Héctor R Pérez-Gómez, and Rodrigo Escobedo-Sánchez, and Gerardo León-Garnica, and Rayo Morfín-Otero
September 2023, Healthcare (Basel, Switzerland),
Eduardo Rodríguez-Noriega, and Elvira Garza-González, and Paola Bocanegra-Ibarias, and Beatriz Alejandra Paz-Velarde, and Sergio Esparza-Ahumada, and Esteban González-Díaz, and Héctor R Pérez-Gómez, and Rodrigo Escobedo-Sánchez, and Gerardo León-Garnica, and Rayo Morfín-Otero
November 2015, The Southeast Asian journal of tropical medicine and public health,
Eduardo Rodríguez-Noriega, and Elvira Garza-González, and Paola Bocanegra-Ibarias, and Beatriz Alejandra Paz-Velarde, and Sergio Esparza-Ahumada, and Esteban González-Díaz, and Héctor R Pérez-Gómez, and Rodrigo Escobedo-Sánchez, and Gerardo León-Garnica, and Rayo Morfín-Otero
April 2011, Journal of clinical microbiology,
Eduardo Rodríguez-Noriega, and Elvira Garza-González, and Paola Bocanegra-Ibarias, and Beatriz Alejandra Paz-Velarde, and Sergio Esparza-Ahumada, and Esteban González-Díaz, and Héctor R Pérez-Gómez, and Rodrigo Escobedo-Sánchez, and Gerardo León-Garnica, and Rayo Morfín-Otero
January 2013, Infection control and hospital epidemiology,
Eduardo Rodríguez-Noriega, and Elvira Garza-González, and Paola Bocanegra-Ibarias, and Beatriz Alejandra Paz-Velarde, and Sergio Esparza-Ahumada, and Esteban González-Díaz, and Héctor R Pérez-Gómez, and Rodrigo Escobedo-Sánchez, and Gerardo León-Garnica, and Rayo Morfín-Otero
June 2017, Microbial drug resistance (Larchmont, N.Y.),
Eduardo Rodríguez-Noriega, and Elvira Garza-González, and Paola Bocanegra-Ibarias, and Beatriz Alejandra Paz-Velarde, and Sergio Esparza-Ahumada, and Esteban González-Díaz, and Héctor R Pérez-Gómez, and Rodrigo Escobedo-Sánchez, and Gerardo León-Garnica, and Rayo Morfín-Otero
February 2012, Microbes and infection,
Eduardo Rodríguez-Noriega, and Elvira Garza-González, and Paola Bocanegra-Ibarias, and Beatriz Alejandra Paz-Velarde, and Sergio Esparza-Ahumada, and Esteban González-Díaz, and Héctor R Pérez-Gómez, and Rodrigo Escobedo-Sánchez, and Gerardo León-Garnica, and Rayo Morfín-Otero
February 2012, Nihon rinsho. Japanese journal of clinical medicine,
Eduardo Rodríguez-Noriega, and Elvira Garza-González, and Paola Bocanegra-Ibarias, and Beatriz Alejandra Paz-Velarde, and Sergio Esparza-Ahumada, and Esteban González-Díaz, and Héctor R Pérez-Gómez, and Rodrigo Escobedo-Sánchez, and Gerardo León-Garnica, and Rayo Morfín-Otero
May 1991, The Journal of hospital infection,
Copied contents to your clipboard!